Supplementary Table S1 from Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor–Positive Breast Cancer in the GEICAM/9906 Trial
Authors:
- Miguel MartínMMMiguel Martín
- Alvaro Rodriguez-LescureARAlvaro Rodriguez-Lescure
- Cristina ReboredoCRCristina Reboredo
- Eveline ChenECEveline Chen
- Manuel Ruiz-BorregoMRManuel Ruiz-Borrego
- Ana Santaballa BertranABAna Santaballa Bertran
- Cesar A. RodríguezCRCesar A. Rodríguez
- Noelia Martinez-JañezNMNoelia Martinez-Jañez
- Emilio AlbaEAEmilio Alba
- Kevin TranKTKevin Tran
- Ignacio Pelaez FernandezIFIgnacio Pelaez Fernandez
- Isabel ÁlvarezIÁIsabel Álvarez
Open Access
- 1 September 2026
- other
- Published by American Association for Cancer Research (AACR)